Press release
Nontuberculous Mycobacterial Infection Market 2024 - By Size, Industry Analysis, Segmentation And Outlook 2033
Nontuberculous Mycobacterial Infection Market
As per the report, the nontuberculous mycobacterial infection market size has grown strongly in recent years. It will grow from $13.43 billion in 2023 to $14.25 billion in 2024 at a compound annual growth rate (CAGR) of 6.1%. The nontuberculous mycobacterial infection market size is expected to see strong growth in the next few years. It will grow to $18.17 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%.
Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=13020&type=smp
Rising Prevalence Of Copd Fuels Growth In The Nontuberculous Mycobacterial Infection Market
The rising prevalence of chronic obstructive pulmonary disease (COPD) is expected to propel the growth of the nontuberculous mycobacterial infection market going forward. Chronic obstructive pulmonary disease (COPD) is a chronic respiratory condition characterized by persistent and often progressive lung airflow limitation. Nontuberculous mycobacterial (NTM) infections in patients with COPD are associated with a more significant decline in forced expiratory volume in one second (FEV1) and an increased exacerbation rate. COPD may weaken the immune system and damage the lung tissue, making it easier for NTM bacteria to infect the lungs. For instance, in March 2023, according to a report published by The Scottish Public Health Observatory (ScotPHO), a Scotland-based public health body, COPD rates began to climb between 2021 and 2022, with male rates increasing from 83.2 to 97.6 per 100,000 persons while female rates increased from 72.6 to 97.3. Therefore, the rising prevalence of chronic obstructive pulmonary disease (COPD) drives the growth of the nontuberculous mycobacterial infection market.
Adoption Of Innovative Treatment Approvals In The Nontuberculous Mycobacterial Infection Market
Major companies operating in the nontuberculous mycobacterial infection market adopt new treatment approval practices to sustain their position in the market. For instance, in June 2021, Paratek Pharmaceuticals Inc., a US-based pharmaceutical company, received approval to expand NUZYRA's (omadacycline) indication for treating community-acquired bacterial pneumonia (CABP) in adults. NUZYRA is a modernized tetracycline specifically designed to overcome tetracycline resistance and exhibits activity across a spectrum of bacteria, including Gram-positive, Gram-negative, atypical and other drug-resistant strains. Further, in July 2022, the Food and Drug Administration, a US-based federal agency, granted Fast Track designation for NUZYRA to treat nontuberculous mycobacterial (NTM) lung disease due to MAC (Mycobacterium avium complex).
The nontuberculous mycobacterial infection market covered in this report is segmented -
1) By Drug Class: Macrolides; Rifampin; Aminoglycoside; Other Drug Classes
2) By Route Of Administration: Oral; Parenteral; Other Routes
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=13020&type=discount
Major players in the nontuberculous mycobacterial infection market are Pfizer Inc., Johnson & Johnson, F. Hoffman La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol Myers Squibb, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company, Eli Lilly and Company, C.H. Boehringer Sohn AG & Co. KG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Astellas Pharma Inc., Vertex Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Horizon Therapeutics PLC, Lupin Limited, BioMarin Pharmaceutical Inc., Ionis Pharmaceuticals Inc., Insmed Incorporated, Paratek Pharmaceuticals Inc., Spero Therapeutics Inc., Aradigm Corporation, Dauntless Pharmaceuticals Inc., Validus Pharmaceuticals LLC.
Contents of the report:
1. Executive Summary
2. Nontuberculous Mycobacterial Infection Market Report Structure
3. Nontuberculous Mycobacterial Infection Market Trends And Strategies
4. Nontuberculous Mycobacterial Infection Market - Macro Economic Scenario
5. Nontuberculous Mycobacterial Infection Market Size And Growth
…..
27. Nontuberculous Mycobacterial Infection Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/nontuberculous-mycobacterial-infection-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nontuberculous Mycobacterial Infection Market 2024 - By Size, Industry Analysis, Segmentation And Outlook 2033 here
News-ID: 3618908 • Views: …
More Releases from The Business research company
Analysis of Key Market Segments Driving the Adenosine Market
The adenosine market is positioned for substantial expansion in the coming years, driven by technological advancements and growing demand in various medical fields. As research and innovation continue to evolve, the market is expected to witness significant progress, offering promising opportunities for industry players and healthcare providers alike. Here is a detailed overview of the current outlook, key players, emerging trends, and market segmentation shaping the future of the adenosine…
Outlook for the Biopharmaceutical Excipients Market: Major Segments, Strategic D …
The biopharmaceutical excipients market is set for remarkable expansion in the coming years as innovations and increasing demand transform drug formulation approaches. With the rise of complex biologic therapies and a stronger focus on safety and stability, this sector is gaining considerable traction. Let's explore the market's size, key drivers, leading companies, emerging trends, and important segments shaping its future.
Projected Market Growth and Size of the Biopharmaceutical Excipients Market …
Outlook on the Acquired Autoimmune Hemolytic Anemia Market: Major Segments, Stra …
The acquired autoimmune hemolytic anemia market is on a promising growth trajectory, driven by advancements in treatment and diagnostic technologies. As awareness of this rare condition rises and personalized therapies become more prevalent, the market is set to expand significantly in the coming years. Let's explore the market's size, key drivers, leading companies, emerging trends, and important segments shaping its future.
Projected Market Value and Expansion of the Acquired Autoimmune Hemolytic…
Emerging Sub-Segments Transforming the 3D Bioprinted Human Tissue Market Landsca …
The emergence of 3D bioprinting technology is revolutionizing the field of human tissue engineering, offering promising prospects for medical research and treatment. With continuous innovations and growing demand across healthcare and pharmaceutical sectors, the 3D bioprinted human tissue market is set for substantial expansion in the years ahead. Let's explore the market size projections, key players, prevailing trends, and segmentation details shaping this fast-evolving industry.
Expected Growth Trajectory of the 3D…
More Releases for Pharma
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
